PRESS RELEASE [Press release] BioPlus Co-develops Next Generation Botulinum Toxin with ProCell Therapeutics
PRESS RELEASE [Press release] BioPlus’s operating profit in 2021 is 18.3 billion won. “The best performance since its foundation”
PRESS RELEASE [Press release] Co-development MOU with BioPlus, Noblegen, and Gachon University for virus treatments was signed
PRESS RELEASE [Press release] Will BioPlus continue its surprise performance next year? It’s about to enter China, the biggest market
PRESS RELEASE [Press release] BioPlus “Anti-adhesion drug, technology transfer with global companies”
PRESS RELEASE [Press release] “Manufacturing industry leader” investment attraction exceeded 100 trillion won (news report)
PRESS RELEASE [Press release] 1 trillion won of Hanwha Solution and 200 billion won of BioPlus investment
PRESS RELEASE [Press release] Bioplus got a product license from the Ministry of Food and Drug Safety for “Blad-Care”, a treatment for cystitis
